Tianyi Zhao | Neuroscience | Research Excellence Award

Published on by Global Academic Awards

Research Excellence Award

Tianyi Zhao
Affiliation The First Hospital of Jilin University
Country China
Scopus ID 55470158900
Documents 13
Citations 439
h-index 8
Subject Area Neuroscience
Event Global Academic Awards

Tianyi Zhao
The First Hospital of Jilin University, China

Tianyi Zhao is a researcher affiliated with The First Hospital of Jilin University, China, whose scholarly activities have contributed to interdisciplinary scientific advancement within the field of neuroscience and related biomedical research areas. The researcher has established an academic profile indexed within Scopus, reflecting measurable citation performance, publication visibility, and collaborative scientific engagement.[1] The recognition associated with the Research Excellence Award acknowledges sustained academic productivity, research dissemination, and scientific contribution within internationally indexed scholarly platforms.

The academic profile demonstrates documented publication activity, citation influence, and participation in research initiatives that contribute to contemporary scientific literature. The award evaluation framework recognizes researchers whose publications exhibit measurable academic impact and whose work supports the advancement of scientific inquiry through peer-reviewed dissemination.[2]

Abstract

The Research Excellence Award recognizes academic distinction demonstrated through publication quality, citation performance, interdisciplinary collaboration, and scholarly influence within the scientific community. Tianyi Zhao has developed a research portfolio indexed in international citation databases, contributing to the advancement of biomedical and neuroscience-related studies through peer-reviewed publications and collaborative scientific investigations.[1] The researcher’s academic metrics, including citation count and h-index, indicate measurable engagement with the global research community and sustained scholarly relevance.[3]

Keywords

Research Excellence Award; Tianyi Zhao; Neuroscience; Scopus Author Profile; Academic Recognition; Citation Impact; Biomedical Research; Scientific Publications; Research Metrics; Global Academic Awards

Introduction

Academic recognition awards serve as formal acknowledgements of scholarly achievement and research productivity within the international scientific ecosystem. Such recognitions commonly evaluate publication metrics, citation performance, research visibility, and contributions to disciplinary advancement.[4] The research profile associated with Tianyi Zhao demonstrates engagement with scientific publication practices and participation in peer-reviewed research dissemination.

The field of neuroscience continues to evolve through interdisciplinary integration involving molecular biology, biomedical technologies, clinical research methodologies, and analytical scientific approaches. Researchers contributing to these domains play an important role in expanding the scientific understanding of neurological systems, disease mechanisms, and translational biomedical applications.[5]

Research Profile

Tianyi Zhao is affiliated with The First Hospital of Jilin University in China and maintains a documented Scopus author profile indexed under Author ID 55470158900. The profile indicates 13 indexed documents, 439 citations, and an h-index value of 8, reflecting measurable scholarly impact across indexed literature sources.[1]

The researcher’s publication history includes scientific studies associated with analytical chemistry, biomedical investigation, and applied scientific methodologies relevant to neuroscience and interdisciplinary biomedical research. Indexed records demonstrate collaborative publication activity and participation in peer-reviewed scientific communication channels.[2]

  • Institutional Affiliation: The First Hospital of Jilin University
  • Research Region: China
  • Indexed Documents: 13
  • Total Citations: 439
  • Scopus h-index: 8
  • Primary Subject Area: Neuroscience

Research Contributions

The scholarly contributions attributed to Tianyi Zhao include participation in scientific investigations related to analytical probes, biomedical detection methodologies, and interdisciplinary research applications. One documented publication involves the synthesis of functionalized CdTe/ZnS nanoparticles for fluorescence detection applications, demonstrating engagement with advanced laboratory methodologies and applied scientific instrumentation.[2]

Research activities within biomedical and neuroscience-related domains frequently require cross-disciplinary integration involving molecular diagnostics, bioanalytical techniques, and translational research processes. Such interdisciplinary contributions support broader scientific understanding and facilitate methodological innovation within contemporary healthcare and life science research environments.[6]

Publications

Selected indexed publications and scholarly contributions associated with Tianyi Zhao include peer-reviewed scientific studies documented through Scopus indexing services and related citation databases.[1]

Research Impact

Research impact is commonly evaluated through citation analytics, publication dissemination, institutional collaboration, and scholarly influence within disciplinary literature. Tianyi Zhao’s citation profile demonstrates engagement from the broader academic community, with citations distributed across multiple scientific documents indexed within international databases.[1]

The h-index value of 8 indicates that multiple publications have achieved measurable citation visibility within scholarly communication networks. Citation performance metrics serve as one indicator of research influence and knowledge dissemination within the scientific ecosystem.[3]

Award Suitability

The Research Excellence Award recognizes researchers whose academic records demonstrate sustained publication activity, citation engagement, interdisciplinary collaboration, and measurable scholarly contribution. Tianyi Zhao’s indexed publication profile, citation metrics, and participation in peer-reviewed scientific dissemination align with evaluation frameworks commonly applied to international academic recognition programs.

The documented research activities and publication visibility support the suitability of the researcher for recognition within global academic award initiatives that emphasize research dissemination, scientific integrity, and contribution to evidence-based scientific advancement.[6]

Conclusion

Tianyi Zhao’s scholarly profile reflects continued engagement with scientific research, publication dissemination, and interdisciplinary collaboration within neuroscience and biomedical research environments. Indexed academic metrics, including citation counts and h-index performance, indicate measurable research visibility and scholarly participation within international scientific literature.[1]

The recognition associated with the Research Excellence Award acknowledges academic productivity, citation-based influence, and contributions to scientific advancement through peer-reviewed research dissemination and collaborative investigation.

References

  1. Elsevier. (n.d.). Scopus author details: Tianyi Zhao, Author ID 55470158900. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55470158900
  2. Zhao, T. et al. (2015). Synthesis of functionalized CdTe/ZnS nanoparticles as probes for norfloxacin fluorescence detection. Chalcogenide Letters.
    https://www.researchgate.net/publication/290528045_Synthesis_of_functionalized_CdTeZnS_nanoparticles_as_probes_for_norfloxacin_fluorescence_detection
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences.
    https://www.pnas.org/doi/10.1073/pnas.0507655102
  4. Kandel, E. R. et al. (2013). Principles of Neural Science. McGraw-Hill Education.
  5. National Institutes of Health. (n.d.). Biomedical and interdisciplinary research initiatives. 

Tumurgan Zolzaya | Medical Research | Young Scientist Award

Published on by Global Academic Awards

Dr. Tumurgan Zolzaya | Medical Research | Young Scientist Award

Dr. Tumurgan Zolzaya (Shimane University Faculty of Medicine, Japan) has published 15 documents with 115 citations, achieving an h-index of 6. The 2024 open-access article in Virology investigates suberoylanilide hydroxamic acid (SAHA) against Epstein–Barr virus (EBV), demonstrating apoptosis induction in infected cells by suppressing BART gene expression and triggering lytic infection. The work contributes to EBV-targeted therapeutic research and translational virology.

 

Citation Metrics (Scopus)

120

100

80

60

40

20

0

Citations 115

Documents 15

h-index
6

Citations
Documents
h-index


View Scopus Profile
   View Google Scholar Profile

Featured Publication

Micaela Dugan | Neurology | Best Researcher Award

Published on by Global Academic Awards

Ms. Micaela Dugan | Neurology | Best Researcher Award

University of Michigan Medical School | United States

Ms. Micaela Dugan demonstrates outstanding research versatility, engaging in both clinical and basic science projects with methodological rigor. With 23 citations, 9 documents, and an h-index of 3, her peer-reviewed publications, correspondence in high-impact journals, and national presentations underscore her scientific credibility. Leadership roles in community health, harm reduction, and advocacy highlight her dedication to translating research into societal impact. Areas for improvement include expanding multi-center collaborations, pursuing longitudinal studies, and strengthening grant-writing experience to support independent research. Her future research potential is significant, particularly in perioperative care, pain management, and substance use interventions, where she can integrate clinical insights with translational approaches to improve patient outcomes. Overall, Ms. Dugan’s combination of rigorous scientific training, productive scholarship, and proactive leadership positions her as an exemplary candidate for the Research for Best Researcher Award. Her ongoing dedication to advancing both knowledge and community health ensures she will continue making transformative contributions to medicine and research.

Profile: Scopus

Featured Publications

Dugan, M. Q. (2025). Antiseizure medication discontinuation: A mixed-methods exploration of factors considered by patients when approaching decision-making. Epilepsy Research.

José Berciano | Neurology | Outstanding Scientist Award

Published on by Global Academic Awards

Prof. José Berciano | Neurology | Outstanding Scientist Award

Prof. José Berciano | University of Cantabria | Spain

Prof. José Berciano is a distinguished neurologist recognized for his extensive contributions to clinical neuroscience. He completed his medical studies at the University of Zaragoza, specializing in neurology, and later defended his doctoral thesis on olivo-ponto-cerebellar atrophy at the University of the Basque Country. He served as Head of the Neurology Department at Hospital Marqués de Valdecilla in Santander until his retirement, and is now Professor Emeritus at the University of Cantabria. His research has focused on ataxias, Charcot-Marie-Tooth disease, and Guillain-Barré syndrome, producing a prolific body of work with thousands of papers indexed in PubMed and an H-index reflecting high scientific impact. Prof. Berciano has held leadership roles in the Spanish Society of Neurology and international consortia such as EUROSCA and IGOS, while also mentoring future generations of neurologists. He remains active in scientific publishing and continues to contribute to neurological research

Publication Profile

Orcid

Education

Prof. José Berciano pursued his medical studies at the University of Zaragoza, where he built a strong foundation in clinical medicine and neuroscience. His specialization in neurology was completed at “Clínica Puerta de Hierro” in Madrid, equipping him with advanced expertise in neurological disorders. He defended his doctoral thesis, “New contributions to the knowledge of olivo-ponto-cerebellar atrophy,” at the University of the Basque Country. His education not only provided him with theoretical knowledge but also instilled a research-oriented approach, preparing him for a lifelong career as a clinician-scientist dedicated to advancing the understanding of neurodegenerative and neuromuscular diseases.

Experience

Prof. José Berciano career spans decades of practice, research, and teaching in neurology. He served at Hospital Universitario Marqués de Valdecilla in Santander, where he was Head of the Neurology Department and trained countless specialists. He was appointed Professor of Neurology at the University of Cantabria and later honored as Professor Emeritus in recognition of his contributions. His international presence includes leadership roles in scientific societies and research consortia such as EUROSCA, IGOS, and CMT. He continues to actively participate in neurological research, writing and reviewing scientific papers, and guiding new generations of clinicians.

Research Focus

Prof. José Berciano research focus lies primarily in the field of clinical neurology, with a strong emphasis on neurodegenerative and neuromuscular disorders. His work has significantly advanced the understanding of Guillain-Barré syndrome, as reflected in his numerous publications ranging from foundational studies on the microscopical anatomy of the peripheral nervous system to clinical analyses of early diagnostic criteria and prospective studies within Spain. His contributions bridge both basic and clinical neuroscience, integrating detailed anatomical knowledge with applied diagnostic and therapeutic insights. In addition to Guillain-Barré syndrome, his broader research has explored ataxias and Charcot-Marie-Tooth disease, offering critical insights into the mechanisms and management of these conditions. Through books, journal articles, and collaborative studies, he has built a comprehensive body of work that informs both research and clinical practice. His category of research focus can be defined as neurology with specialization in peripheral neuropathies, neurodegeneration, and clinical neurophysiology.

Publication Top Notes

Microscopical anatomy of the peripheral nervous system: An essential notion for understanding the pathophysiology of very early classic Guillain-Barré syndrome
Year: 2025 
Citations: 2

Re-evaluating the accuracy of optimized electrodiagnostic criteria in very early Guillain-Barré syndrome: a sequential study
Year: 2021

A unicenter, prospective study of Guillain-Barré syndrome in Spain
Year: 2019

Guillain-Barré syndrome (Book, Lambert Academic Publishing)
Year: 2015

Conclusion

Prof. José Berciano distinguished career, prolific publications, and significant contributions to neurology make him a highly suitable candidate for the Research for Outstanding Scientist Award. His expertise in neurodegenerative disorders and rare diseases has shaped the field globally. With clearer emphasis on recent contributions and collaborations, his candidacy would stand as an outstanding example of lifetime scientific achievement.

Francesco Latini | White matter | Best Researcher Award

Published on by Global Academic Awards

Assoc. Prof. Dr. Francesco Latini | White matter | Best Researcher Award

Assoc. Prof. Dr. Francesco Latini, Uppsala University Hospital, Sweden

Assoc. Prof. Dr. Francesco Latini, M.D., Ph.D., is an Associate Professor in Neurosurgery at Uppsala University Hospital, Sweden. His expertise spans general neurosurgery, neuro-oncology, and cerebrovascular diseases. With a deep interest in brain connectivity and gliomas, Dr. Latini has contributed significantly to advancing neurosurgical practices. He leads the Neurointermediate Intensive Care Unit and coordinates regional clinical processes for malignant brain tumors. 🌍🧠💉

Publication Profile

Google Scholar

Education

Dr. Latini graduated in 2006 from the University of Bologna, Italy. He completed his specialization in Neurosurgery in 2013 (cum laude) at the University of Ferrara, Italy. In 2021, he earned a Ph.D. in Medical Sciences from Uppsala University, focusing on the anatomy and behavior of low-grade gliomas. His training includes specialized fellowships in neurovascular surgery and neuro-oncology at various prestigious institutions worldwide. 🎓📚🏥

Experience

Dr. Latini’s career spans from Resident in Neurosurgery at S.Anna University-Hospital, Ferrara (2008-2013) to roles in Uppsala University-Hospital since 2014. He has held positions as a ward physician, junior consultant, and senior consultant in neurosurgery. Currently, he heads the Neurointermediate Intensive Care Unit and serves as the regional coordinator for malignant brain tumor clinical processes. He is also an associate professor in neurosurgery. 🏥🧑‍⚕️💼

Awards and Honors

Dr. Latini has received numerous awards for his contributions to neurosurgery, including recognition for his work in neuro-oncology and cerebrovascular diseases. He is highly regarded in both research and clinical practice and has been acknowledged for his clinical leadership in brain tumor management and neurosurgical innovation. His honors reflect his excellence in both teaching and surgical practice. 🏆🎖️🌟

Research Focus

Dr. Latini’s research primarily focuses on the role of white matter anatomy in the behavior and surgical treatment of low-grade gliomas. He explores the radiological and histopathological features of diffuse gliomas, aiming to develop new models for their treatment. His work bridges the gap between clinical neurosurgery and advanced imaging technologies, emphasizing preoperative planning and patient outcomes. 🧠🔬

Publication Top Notes

  • Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III – Cited by: 118 – Year: 2014 🧠📑

  • Segmentation of the inferior longitudinal fasciculus in the human brain: A white matter dissection and diffusion tensor tractography study – Cited by: 117 – Year: 2017 🧠📊

  • Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data – Cited by: 80 – Year: 2016 🧠🩻

  • The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power – Cited by: 58 – Year: 2018 🧠⚖️

  • New insights in the limbic modulation of visual inputs: The role of the inferior longitudinal fasciculus and the Li-Am bundle – Cited by: 55 – Year: 2014 🧠🔬

  • Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up – Cited by: 49 – Year: 2011 🧠💉

  • Time course of neurological deficits after surgery for primary brain tumours – Cited by: 47 – Year: 2020 🧠🕰️

  • Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry – Cited by: 46 – Year: 2014 🧠📈

  • Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson’s disease – Cited by: 46 – Year: 2010 🧠⚖️

  • Is the resection of gliomas in Wernicke’s area reliable? – Cited by: 45 – Year: 2012 🧠💬

  • miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time PCR – Cited by: 39 – Year: 2012 🧠🔬

  • The use of a cerebral perfusion and immersion–fixation process for subsequent white matter dissection – Cited by: 34 – Year: 2015 🧠⚙️

  • Mobilization of the transcavernous oculomotor nerve during basilar aneurysm surgery: biomechanical bases for better outcome – Cited by: 34 – Year: 2014 🧠⚙️

  • New insights into the anatomy, connectivity and clinical implications of the middle longitudinal fasciculus – Cited by: 33 – Year: 2021 🧠🌐

  • Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference – Cited by: 32 – Year: 2013 🧠📚

Beatriz Veiga | Neuroscience | Best Researcher Award

Published on by Global Academic Awards

Dr. Beatriz Veiga | Neuroscience | Best Researcher Award

Dr. Beatriz Veiga, Universidade Federal de São Paulo, Brazil

Dr. Beatriz Azevedo dos Anjos Godke Veiga is a Brazilian neurologist with a focus on movement disorders. She completed her medical degree in 2001 at Universidade Estadual de Londrina, followed by a Master’s and Doctorate in Neurology/Neurosciences at Universidade Federal de São Paulo (UNIFESP). Her doctoral research, completed in 2023, examined the association between compulsive behaviors and levodopa-induced dyskinesias in Parkinson’s disease patients. Dr. Veiga is currently a neurologist at Hospital Ipiranga and a faculty member at Universidade Nove de Julho. Her research interests include impulsive behaviors, dyskinesias, and Parkinson’s disease. She has received multiple awards, including the International Congress Travel Grant Award from the Movement Disorders Society in 2019 and 2022. Her published work includes articles on depression in Parkinson’s disease and fatigue in geriatric patients. Dr. Veiga is actively involved in several research projects, particularly those exploring the relationship between early-onset Parkinson’s disease and dopamine agonists.

Publication Profile

Orcid

Awards and Titles 🏆

Dr. Beatriz Veiga has earned significant recognition in the field of movement disorders. In 2022, she was awarded the International Congress Travel Grant Award by the Movement Disorders Society 🌍, highlighting her contributions and research in this specialized area. This prestigious honor was preceded by another International Congress Travel Grant Award in 2019, further solidifying her standing within the international scientific community. Dr. Veiga’s continuous dedication to advancing the understanding of movement disorders has positioned her as a prominent figure in the field, earning accolades for her expertise and commitment to research. 🌟

 

Academic Background 🎓

Dr. Beatriz Veiga’s academic journey has been marked by excellence in the field of Neurology and Neurosciences. She completed her PhD in Neurology/Neurosciences at the Federal University of São Paulo (UNIFESP), Brazil, in 2023, with a thesis on the association between compulsive impulsive behaviors and levodopa-induced dyskinesias in Parkinson’s disease patients 🧠. Dr. Veiga also holds a Master’s degree from UNIFESP (2008), focusing on depression in Parkinson’s disease. Her medical residency in Neurology was completed at the State University of Londrina (UEL), Brazil, where she was a CNPq scholar. She holds a degree in Medicine from UEL (2001). 🎓

 

Complementary Education 📚

Dr. Beatriz Veiga has enhanced her expertise in Neurology through specialized training. In 2019, she completed a short course in Deep Brain Stimulation (DBS) at the International Academy, gaining 25 hours of focused learning on this advanced therapy for movement disorders 🧠. She also participated in an Observership program at the Movement Disorders Clinic, University of Toronto, with a focus on DBS, accumulating 160 hours of hands-on experience. Dr. Veiga is a Neurologist and Preceptor at Hospital Ipiranga, and a faculty member at the University of Nove de Julho, specializing in movement disorders. 💡

 

Professional Experience 🏥

Dr. Beatriz Veiga has extensive professional experience in Neurology and academia. Since 2008, she has been a Full Member of the Academia Brasileira de Neurologia (ABN). She is also an active member of the Movement Disorder Society (MDS) since 2017. Dr. Veiga is a Faculty Member at the University of Nove de Julho (UNINOVE) since 2012, where she teaches in the Medicine program 🩺. Additionally, she has served as a Neurologist and Preceptor at Hospital Ipiranga since 2010, training the next generation of neurologists. Her expertise has been pivotal in the field of movement disorders. 🌟

 

Research Focus

Dr. Beatriz A. Anjos G. Veiga’s research primarily focuses on neurology and movement disorders, specifically the relationship between impulsive-compulsive behaviors (ICBs) and Levodopa-induced dyskinesia (LID) in Parkinson’s disease. Her work, demonstrated in the study “Are Impulsive Compulsive Behaviors Associated with Levodopa-Induced Dyskinesia?”, explores how these behaviors contribute to the clinical presentation of Parkinson’s disease and its treatment. She investigates the neurophysiological mechanisms behind these effects, aiming to improve therapeutic strategies. Her research contributes significantly to understanding the cognitive and motor complications of Parkinson’s disease and optimizing management strategies. 🩺🔬

 

Publication Top Notes

Are Impulsive Compulsive Behaviors Associated with Levodopa-Induced Dyskinesia? A Brazilian Cross-Sectional Study

Gaiqing Wang | Neurodegeneration Disease | Research and Development Excellence Award

Published on by Global Academic Awards

Prof. Gaiqing Wang | Neurodegeneration Disease | Research and Development Excellence Award

Prof. Gaiqing Wang, Sanya Central Hospital (The Third People’s Hospital of Hainan Province), China

Prof. Gaiqing Wang is a distinguished neurologist affiliated with Sanya Central Hospital, Hainan Province, specializing in cerebrovascular diseases. Holding a Ph.D. from Central South University, he focuses on cerebral small vessel disease and endogenous waste clearance in the brain. With over 70 publications, including 27 SCI-indexed papers, Prof. Wang investigates mechanisms of intracerebral hemorrhage and neurodegenerative disorders. He leads numerous research projects funded by national and provincial bodies, exploring innovative therapeutic approaches. His contributions extend to consultancy, industry projects, and authoring books and patents. A member of prestigious professional societies, his work bridges neuroscience research with clinical applications 🧠🔬.

Publication profile

Orcid

Academic and Professional Background 🎓

Gaiqing Wang, currently serving as a Professor at Sanya Central Hospital, earned a Ph.D. in Neurology from Central South University in 2006. Specializing in cerebral small vessel disease and brain waste clearance mechanisms, Wang has authored over 70 papers and secured funding for 13 research projects. His impactful contributions include elucidating the role of microglia in hematoma clearance post-intracerebral hemorrhage and exploring circadian regulation of brain clearance systems. Wang’s academic prowess is underscored by leadership in consultancy projects and publication of several books and patents, consolidating his standing as a distinguished figure in neurological research.

Research Focus

Gaiqing Wang primarily focuses on neuroinflammation and neuroprotection in various neurological disorders, prominently in conditions like Alzheimer’s disease, intracerebral hemorrhage, and subarachnoid hemorrhage. His research explores mechanisms involving oxidative stress, microglial activation, and therapeutic interventions such as dexmedetomidine and PPAR-γ agonists. Wang’s work spans across multiple facets of brain injury and repair, emphasizing the roles of microglia, astrocytes, and clearance systems in these pathological processes. His contributions highlight the intricate signaling pathways and potential therapeutic targets 🧠🔬, advancing understanding and treatment strategies for severe neurological conditions.

Publication Top Notes

Dexmedetomidine mitigates neuroinflammation in an Alzheimer’s disease mouse model via the miR-204-3p/FBXL7 signaling axis

Published in Brain Research (2024)
Year of Publication: 2024 🧠
Neuroprotection by Nrf2 via modulating microglial phenotype and phagocytosis after intracerebral hemorrhage

Published in Heliyon (2023)
Year of Publication: 2023 🧠
Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders

Published in Neurobiology of Disease (2023)
Year of Publication: 2023 🧠
Clearance Systems in the Brain, From Structure to Function

Published in Frontiers in Cellular Neuroscience (2022)
Year of Publication: 2022 🧠
Editorial: Brain injury and repair following cerebrovascular diseases: From bench to bedside

Published in Frontiers in Cellular Neuroscience (2022)
Year of Publication: 2022 🧠

Linjing Mu | Brain PET Imaging Award | Best Researcher Award

Published on by Global Academic Awards

Dr. Linjing Mu | Brain PET Imaging Award | Best Researcher Award

Dr. Linjing Mu, ETH Zurich, Switzerland

🔬 Dr. Linjing Mu pursued doctoral research at Nankai University, followed by a post-doctoral fellowship at Basel University, Switzerland. With expertise in radiopharmaceutical sciences, Dr. Mu led research teams at University Hospital Zurich and ETH Zurich, focusing on lead structure discovery, ligand synthesis, and radiolabeling method development. A prolific author, Dr. Mu has 106 peer-reviewed publications, including 10 as last and corresponding author, and 19 as the first author. Co-investigator on 10 patents, Dr. Mu has presented internationally and collaborated with industry leaders like Bayer Schering, Novartis, and Roche, contributing significantly to drug discovery and clinical translations.

 

Publication Profile:

Scopus

Orcid

Education:

Doctoral Research in Chemistry Department, Nankai University (1993-1996)

Post-Doctoral Fellow, Basel University, Switzerland (1996-2001)

Experience:

Team Leader in the field of Radiopharmaceutical Sciences, Group of Prof. Schubiger (2001-2010)

Head of Research, Radiopharmacy, University Hospital Zurich (2010-2021)

Senior Scientist, Prof. Schibli’s Group, ETH Zurich (2021-Present)

Research Expertise:

Lead Structure Finding based on Literature and Patents

Design and Synthesis of Novel Ligands

Structure-Activity Relationship Studies

Radiolabeling Method Development

In Vitro and In Vivo Evaluation

Academic Achievements:

Co-authored 106 Peer-Reviewed Publications

Last and Corresponding Author on 10, First Author on 19 (H-Factor 29, Scopus)

Co-Investigator on 10 Patent Applications

Contributed to International Conferences as Invited Speaker, Oral and Poster Presenter

Research Focus:

🔬 Dr. Linjing Mu’s research focus lies at the intersection of neuroimaging and drug development, particularly in the field of molecular imaging for neurodegenerative diseases like Alzheimer’s. Their work encompasses the development and optimization of radioligands targeting specific molecular pathways implicated in neurodegeneration. Through PET/MRI studies and the exploration of novel PET tracers, such as (R)-[18F]YH134 and (R)-[18F]PSS232, Dr. Mu aims to deepen our understanding of disease mechanisms and identify potential therapeutic targets. This research not only sheds light on disease pathology but also paves the way for the development of new diagnostic tools and pharmacological interventions.

 

Publication Top Notes:

📄 Wang, J. et al. Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer’s disease: A [18F]PSS232 PET/MRI study. Published in Alzheimer’s Research and Therapy, 2024. Cited by: 0.

📄 He, Y. et al. Identification of (R)-[18F]YH134 for Monoacylglycerol Lipase Neuroimaging and Exploration of Its Use for Central Nervous System and Peripheral Drug Development. Published in Journal of Nuclear Medicine, 2024. Cited by: 0.

📄 Boccalini, C. et al. The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline. Published in Alzheimer’s and Dementia, 2024. Cited by: 1.

📄 Trachsel, B. et al. Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK. Published in EJNMMI Radiopharmacy and Chemistry, 2023. Cited by: 0.

📄 Lu, Y. et al. Proof-of-concept optimization of a copper-mediated 18F-radiosynthesis of a novel MAGL PET tracer on a high-throughput microdroplet platform and its macroscale translation. Published in Lab on a Chip, 2023. Cited by: 1.

📄 Ni, R. et al. Imaging increased metabolism in the spinal cord in mice after middle cerebral artery occlusion. Published in Photoacoustics, 2023. Cited by: 0.

📄 Zechner, M. et al. In Vitro and In Vivo Evaluation of ABCG2 (BCRP) Inhibitors Derived from Ko143. Published in Journal of Medicinal Chemistry, 2023. Cited by: 1.

📄 Bengs, S. et al. Rest/stress myocardial perfusion imaging by positron emission tomography with 18F-Flurpiridaz: A feasibility study in mice. Published in Journal of Nuclear Cardiology, 2023. Cited by: 3.

📄 Peretti, D.E. et al. ATN profile classification across two independent prospective cohorts. Published in Frontiers in Medicine, 2023. Cited by: 0.

📄 He, Y. et al. Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain. Published in European Journal of Medicinal Chemistry, 2022. Cited by: 2.